Urovant Sciences competitorsClear all

Urovant Sciences's top competitors include Novartis, Pfizer, Takeda Pharmaceutical, Astellas Pharma and Kymera Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Urovant Sciences
Urovant Sciences
Urovant Sciences is a biopharmaceutical company focused on developing novel therapies for urologic conditions.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
Astellas Pharma
Astellas Pharma
Astellas Pharma is a pharmaceutical company focused on the development of drugs and medical solutions.
Kymera Therapeutics
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
Founding Date
Founding Date
2016
Founding Date
1996
Founding Date
1849
Founding Date
1781
Founding Date
1923
Founding Date
2017
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Irvine, US HQ
Basel, CH
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Melbourne, AU
Mulgrave, AU
Sydney, AU
see more
Locations
Tokyo, JP HQ
The Rocks, AU
Linz, AT
Wien, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Toronto, CA
see more
Locations
Tokyo, JP HQ
Macquarie Park, AU
Wien, AT
Vilvoorde, BE
São Paulo, BR
Markham, CA
Beijing, CN
see more
Locations
Watertown, US HQ
Employees
Employees
3950% increase
Employees
105,7942% increase
Employees
88,3004% decrease
Employees
47,4954% decrease
Employees
15,8832% decrease
Employees
1193% increase
Valuation ($)
Valuation ($)
531.8 m
Valuation ($)
N/A
Valuation ($)
231.7 b
Valuation ($)
44.1 b
Valuation ($)
31.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
156
Twitter followers
295.8 k
Twitter followers
29 k
Twitter followers
N/A
Twitter followers
50.4 k
Twitter followers
2.3 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
25
Number of tweets (last 30 days)
12
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.6
Average likes per tweet (last 30 days)
18.5
Average likes per tweet (last 30 days)
12.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.8
Average likes per tweet (last 30 days)
6.1
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
29.41%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
96%
Percentage of tweets with engagement (last 30 days)
91.67%
Alexa Website Rank
Alexa Website Rank
283265
Alexa Website Rank
106045
Alexa Website Rank
26888
Alexa Website Rank
183252
Alexa Website Rank
191144
Alexa Website Rank
175268
Employee Rating
Employee Rating
5
Employee Rating
4.2
Employee Rating
4.2
Employee Rating
3.9
Employee Rating
4
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$48.7b (FY, 2020)
Revenue (est.)
$41.9b (FY, 2020)
Revenue (est.)
¥3.3t (FY, 2020)
Revenue (est.)
¥1.3t (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$15.1b (FY, 2020)
Cost of goods
$8.7b (FY, 2020)
Cost of goods
¥1.1t (FY, 2020)
Cost of goods
¥276.7b (FY, 2020)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$33.5b (FY, 2020)
Gross profit
$33.2b (FY, 2020)
Gross profit
¥2.2t (FY, 2020)
Gross profit
¥1t (FY, 2020)
Gross profit
N/A
Net income
Net income
($146.7m) (FY, 2020)
Net income
$8.1b (FY, 2020)
Net income
$9.7b (FY, 2020)
Net income
¥44.3b (FY, 2020)
Net income
¥195.4b (FY, 2020)
Net income
N/A

Operating

Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
1 (Jul, 2019)
Phase I Trials Products (Oncology)
1 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
51 (Q4, 2020)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
3 (Oct, 2020)
Phase I/II Trials Products (Oncology)
N/A
Phase I/II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
8 (Oct, 2019)
Phase II Trials Products (Oncology)
1 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
44 (Q4, 2020)
Phase III Trials Products
23 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
22 (Q4, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
5 (Oct, 2020)
Phase III Trials Products (Oncology)
4 (Oct, 2020)
Phase III Trials Products (Oncology)
N/A
Registration Phase Products
Registration Phase Products
N/A
Registration Phase Products
5 (Q4, 2020)
Registration Phase Products
9 (FY, 2019)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
$ 197m
For sources of this data, please see the company profile

View company profiles

Novartis
HQ
Basel, CH
Employees
105,794↑ 2% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Pfizer
HQ
New York, US
Employees
88,300↓ 4% decrease

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company
Takeda Pharmaceutical
HQ
Tokyo, JP
Employees
47,495↓ 4% decrease

Takeda Pharmaceutical is a biopharmaceutical company.

View company
Astellas Pharma
HQ
Tokyo, JP
Employees
15,883↓ 2% decrease

Astellas Pharma is a pharmaceutical company focused on the development of drugs and medical solutions.

View company